Information about BioFexhe
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0746.657.302

VAT liability
Yes
Established
04-05-2020
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Commercial name
BioForce
Principal activity
Support activities for animal production
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from BioFexhe

2025 2024 2023 2022
Income statement
Profit/Loss € -9,333 -155% € -3,660 64% € -10,267 17% € -12,387
Gross margin € -6,205 -70% € -3,660 51% € -7,433 36% € -11,631
Balance sheet
Balance sheet total € 10,207 -17% € 12,252 -1% € 12,331 -23% € 16,053
Equity € -49,326 -23% € -39,993 -10% € -36,333 -39% € -26,067
Debts € 59,533 14% € 52,246 7% € 48,664 16% € 42,120

Publications from BioFexhe

Date Publication
06-05-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of BioFexhe?
The VAT number of BioFexhe is BE 0746.657.302.
Wat is the PEPPOL ID of BioFexhe?
The PEPPOL ID of BioFexhe is 0208:0746657302. Log in or start a free trial to see the full overview.
When was BioFexhe founded?
BioFexhe was founded on 04-05-2020.
What is the address of BioFexhe?
The current registered office of BioFexhe is located at Rue de Goreux 26, 4347 Fexhe-le-Haut-Clocher.
When was the last time BioFexhe filed their annual financial statements?
The most recent financial statements of BioFexhe were filed on 20-09-2026.
How many employees does BioFexhe have?
There are currently no employees working at BioFexhe or no workforce information is available.
What is the annual turnover of BioFexhe?
At the time of its most recent financial statements, BioFexhe did not publish any turnover figures. BioFexhe reported a gross margin of -€6,205.00.